{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:19:24Z","timestamp":1791839964429,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jaad.2021.07.007","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T01:51:36Z","timestamp":1626141096000},"page":"761-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy"],"prefix":"10.1016","volume":"87","author":[{"given":"Roberto","family":"Maglie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Ugolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Logu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Nassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Simi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Nardiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pasqualini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Del Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Massi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Antiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2021.07.007_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaad.2018.11.048","article-title":"Eosinophilic dermatosis of hematologic malignancy: a retrospective cohort of 37 patients from an Italian center","volume":"81","author":"Grandi","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.07.007_bib2","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1111\/jdv.15452","article-title":"Cutaneous eruptions associated with haematologic malignancies: the need for a unifying nomenclature","volume":"33","author":"Maglie","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2021.07.007_bib3","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/jdv.14805","article-title":"T-cell papulosis associated with B-cell malignancy: a distinctive clinicopathologic entity","volume":"32","author":"Visseaux","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.jaad.2021.07.007_bib4","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamadermatol.2020.3999","article-title":"Generalized pruriginous eruption on a patient with leukemia","volume":"156","author":"N\u00fa\u00f1ez-Hip\u00f3lito","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.07.007_bib5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1600-0560.2012.01906.x","article-title":"Eosinophilic dermatosis of hematologic malignancy","volume":"39","author":"Farber","year":"2012","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1016\/j.jaad.2021.07.007_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/JLB.MR0618-226R","article-title":"The multiple faces of CD5","volume":"105","author":"Burgue\u00f1o-Bucio","year":"2019","journal-title":"J Leukoc Biol"},{"issue":"7","key":"10.1016\/j.jaad.2021.07.007_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/jamadermatol.2015.2","article-title":"Immunologic overlap of helper T-cell subtypes 17 and 22 in erythrodermic psoriasis and atopic dermatitis","volume":"151","author":"Moy","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.07.007_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/cei.12073","article-title":"Increased frequency of skin-infiltrating FoxP3+ regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma","volume":"172","author":"Hanafusa","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.jaad.2021.07.007_bib9","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1600-0625.2011.01378.x","article-title":"Lesional Th17 cells and regulatory T cells in bullous pemphigoid","volume":"20","author":"Arakawa","year":"2011","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.07.007_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaad.2019.07.060","article-title":"Pathophysiologic mechanisms of itch in bullous pemphigoid","volume":"83","author":"Hashimoto","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.07.007_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5114\/ada.2020.96260","article-title":"The ambiguous pruritogenic role of interleukin-31 in cutaneous T-cell lymphomas in comparison to atopic dermatitis: a review","volume":"37","author":"Olszewska","year":"2020","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jaad.2021.07.007_bib12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fimmu.2019.01383","article-title":"Role of the pruritic cytokine IL-31 in autoimmune skin diseases","volume":"10","author":"Gibbs","year":"2019","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.jaad.2021.07.007_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00403-019-01954-5","article-title":"Epidermal expression of eotaxins and thymic stromal lymphopoietin in eosinophil rich dermatoses","volume":"311","author":"Valdebran","year":"2019","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"10.1016\/j.jaad.2021.07.007_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/ijd.13807","article-title":"Bullous eruption in a patient with B-cell chronic lymphocytic leukemia: a diagnostic challenge","volume":"56","author":"Maglie","year":"2017","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.07.007_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2017.05.006","article-title":"Association of bullous pemphigoid with malignancy: a systematic review and meta-analysis","volume":"77","author":"Atzmony","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.07.007_bib16","article-title":"Comment on \u201cassociation of bullous pemphigoid with malignancy: a systematic review and meta-analysis\u201d","author":"Maglie","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.07.007_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaci.2018.02.044","article-title":"TH1\/TH17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planus","volume":"142","author":"Schmidt","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2021.07.007_bib18","article-title":"Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris","author":"Ernst","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2021.07.007_bib19","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3389\/fonc.2019.01435","article-title":"Autoimmune cytopenias in chronic lymphocytic leukemia: focus on molecular aspects","volume":"9","author":"Fattizzo","year":"2019","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2021.07.007_bib20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaad.2020.05.128","article-title":"Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry","volume":"83","author":"Bosma","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.07.007_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa1917006","article-title":"Trial of nemolizumab and topical agents for atopic dermatitis with pruritus","volume":"383","author":"Kabashima","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2021.07.007_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2020.01.089","article-title":"Dupilumab as a novel therapy for bullous pemphigoid: a multicenter case series","volume":"83","author":"Abdat","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.07.007_bib23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jdcr.2019.07.026","article-title":"Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia","volume":"5","author":"Jin","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.jaad.2021.07.007_bib24","doi-asserted-by":"crossref","first-page":"e13725","DOI":"10.1111\/dth.13725","article-title":"Targeted inhibition of IL-4\/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy","volume":"33","author":"Goyal","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2021.07.007_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17232","article-title":"Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy","author":"Maglie","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2021.07.007_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coph.2018.12.007","article-title":"Pharmacological advances in pemphigoid","volume":"46","author":"Maglie","year":"2019","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"10.1016\/j.jaad.2021.07.007_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1365-2133.2012.10966.x","article-title":"Insect bite-like reactions in a patient with B-cell chronic lymphocytic leukaemia: fluorescence in situ hybridization analysis revealed neoplastic B cells within the skin infiltrate","volume":"167","author":"Mitteldorf","year":"2012","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.07.007_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/cup.13389","article-title":"Eosinophilic dermatosis of hematologic malignancy: correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy","volume":"46","author":"Meiss","year":"2019","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2021.07.007_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/ced.14761","article-title":"A case of chronic lymphocytic leukemia-associated insect bite-like reaction responding to ibrutinib, an immunomodulatory bruton\u2019s tyrosine kinase inhibito","author":"Wimalachandra","year":"2021","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.07.007_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s40257-020-00520-4","article-title":"Eosinophilic dermatoses: recognition and management","volume":"21","author":"Marzano","year":"2020","journal-title":"Am J Clin Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221020909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221020909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:03:11Z","timestamp":1759273391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221020909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0190962221020909"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.07.007","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}